Topics: Health, Health News, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Xarelto, Xarelto Lawsuit

 

Topics: IVC Filter, Health News, Medical, Medical News, The Law Offices of Foster & Houston, IVC Lawsuit, Ryan Foster, Foster & Houston, IVC Filter Lawsuit, Medical Update

 

Topics: Health News, Heartburn, Kidney Disease, Kidney Damage, The Law Offices of Foster & Houston, Nexium, FANDHLAW, Nexium Lawsuit, Prilosec, PPI, PPI Lawsuit, Heartburn Drug Lawsuit, Ryan Foster, Foster & Houston, Heartburn Drugs, Prilosec Lawsuit, GERD Drug, GERD Drugs

A study covered in the Harvard Health Publications blog finds Pradaxa users have a higher bleeding risk compared to Warfarin users. In this post, Howard LeWine, M.D., discusses Pradaxa research and shares his professional opinion about blood-thinners.

Topics: Health, Health News, Pradaxa, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Pradaxa Lawsuit, Ryan Foster, Foster & Houston, Mechanical Heart Valves, Juliet Foster, Julie Foster, Harvard Health

 

Topics: Health News, Science, Burn Injury, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Burn Lawsuit, Ryan Foster, Foster & Houston, Burn Technology, Burn Injury Lawsuit

Actos, a drug prescribed to help control blood sugar levels in those with Type 2 diabetes, has been linked to a number of catastrophic health complications including bladder cancer. The FDA has announced that use of Actos for more than one year may be associated with an increased risk of bladder cancer and death.

Topics: Health, Health News, Actos, Bladder Cancer, Actos Lawsuit, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston

In 2012, a federal advisory panel voted against expanding the use of the anticoagulant drug Xarelto. According to the New York Times, the panel found that dangerous bleeding associated with Xarelto outweighed evidence that the drug helps reduce the risk of blood clots.

Topics: Health, Health News, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Xarelto, Xarelto Lawsuit

The FDA has received multiple reports of product issues and adverse events associated with IVC filters. In fact, from 2005 to 2010 alone the FDA received 921 device adverse event reports.

Topics: IVC Filter, Health News, Medical, Medical News, The Law Offices of Foster & Houston, IVC Lawsuit, Ryan Foster, Foster & Houston, IVC Filter Lawsuit, Medical Update

Pradaxa should not be used to prevent stroke or blood clots in patients with medical heart valves, according to the U.S. Food and Drug Administration (FDA). In this safety communication the FDA states Pradaxa users with mechanical prosthetic heart valves are more likely to experience stroke, heart attack, and blood clots than Warfarin users.

Topics: Health, Health News, Pradaxa, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Pradaxa Lawsuit, Ryan Foster, Foster & Houston, Mechanical Heart Valves

AN NBC Nightly News Investigation

 

Topics: IVC Filter, Health News, The Law Offices of Foster & Houston, IVC Lawsuit, Ryan Foster, Foster & Houston, IVC Filter Lawsuit